Table 2 Description of HR-HPV evolution from baseline to follow-up (24 months after baseline) according to the number of HR-HPV detected at baseline. The results obtained at follow-up are reported as absolute number and relative percentage within the specific subgroup
Total number at baseline | Follow-up | ||||||
|---|---|---|---|---|---|---|---|
Neg | non-HR | 1 HR-HPV | 2 HR-HPV | 3 HR-HPV | ≥4 HR-HPV | ||
n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | ||
1 HR-HPV at baseline | 59 | 6 (10.2) | 12 (20.3) | 24 (40.7) | 7 (11.9) | 8 (13.5) | 2 (3.4) |
2 HR-HPV at baseline | 30 | 2 (6.7) | 4 (13.3) | 9 (30) | 4 (13.3) | 6 (20) | 5 (16.7) |
3 HR-HPV at baseline | 16 | 0 | 4 (25) | 4 (25) | 1 (6.3) | 5 (31.2) | 2 (12.5) |
4 HR-HPV at baseline | 3 | 0 | 0 | 0 | 2 (66.7) | 1 (33.3) | 0 |